252 related articles for article (PubMed ID: 38257820)
1. mRNA Vaccine Nanoplatforms and Innate Immunity.
Wei L; Dong C; Zhu W; Wang BZ
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257820
[TBL] [Abstract][Full Text] [Related]
2. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.
Cao Q; Fang H; Tian H
Biomaterials; 2024 Oct; 310():122628. PubMed ID: 38820767
[TBL] [Abstract][Full Text] [Related]
3. mRNA vaccine designs for optimal adjuvanticity and delivery.
Mochida Y; Uchida S
RNA Biol; 2024 Jan; 21(1):1-27. PubMed ID: 38528828
[TBL] [Abstract][Full Text] [Related]
4. Innate sensing of mRNA vaccines.
Wuebben C; Bartok E; Hartmann G
Curr Opin Immunol; 2022 Dec; 79():102249. PubMed ID: 36334350
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
Han X; Alameh MG; Butowska K; Knox JJ; Lundgreen K; Ghattas M; Gong N; Xue L; Xu Y; Lavertu M; Bates P; Xu J; Nie G; Zhong Y; Weissman D; Mitchell MJ
Nat Nanotechnol; 2023 Sep; 18(9):1105-1114. PubMed ID: 37365276
[TBL] [Abstract][Full Text] [Related]
6. Emergence of mRNA vaccines in the management of cancer.
Mohamad Razif MI; Nizar N; Zainal Abidin NH; Muhammad Ali SN; Wan Zarimi WNN; Khotib J; Susanti D; Mohd Jailani MT; Taher M
Expert Rev Vaccines; 2023; 22(1):629-642. PubMed ID: 37401128
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of mRNA-based vaccines.
Iavarone C; O'hagan DT; Yu D; Delahaye NF; Ulmer JB
Expert Rev Vaccines; 2017 Sep; 16(9):871-881. PubMed ID: 28701102
[TBL] [Abstract][Full Text] [Related]
8. Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.
Linares-Fernández S; Lacroix C; Exposito JY; Verrier B
Trends Mol Med; 2020 Mar; 26(3):311-323. PubMed ID: 31699497
[TBL] [Abstract][Full Text] [Related]
9. Emerging advances in delivery systems for mRNA cancer vaccines.
Jiang Z; Xu Y; Du G; Sun X
J Control Release; 2024 Jun; 370():287-301. PubMed ID: 38679162
[TBL] [Abstract][Full Text] [Related]
10. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.
Kowalczyk A; Doener F; Zanzinger K; Noth J; Baumhof P; Fotin-Mleczek M; Heidenreich R
Vaccine; 2016 Jul; 34(33):3882-93. PubMed ID: 27269061
[TBL] [Abstract][Full Text] [Related]
11. Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.
Saresella M; Piancone F; Marventano I; Hernis A; Trabattoni D; Invernizzi M; La Rosa F; Clerici M
Front Immunol; 2022; 13():947320. PubMed ID: 36072604
[TBL] [Abstract][Full Text] [Related]
12. An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses.
Oyama R; Ishigame H; Tanaka H; Tateshita N; Itazawa M; Imai R; Nishiumi N; Kishikawa JI; Kato T; Anindita J; Nishikawa Y; Maeki M; Tokeshi M; Tange K; Nakai Y; Sakurai Y; Okada T; Akita H
ACS Nano; 2023 Oct; 17(19):18758-18774. PubMed ID: 37814788
[TBL] [Abstract][Full Text] [Related]
13. Influenza Viruses: Innate Immunity and mRNA Vaccines.
Lee S; Ryu JH
Front Immunol; 2021; 12():710647. PubMed ID: 34531860
[TBL] [Abstract][Full Text] [Related]
14. Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines.
Matsumura T; Takano T; Takahashi Y
Int Immunol; 2023 May; 35(5):213-220. PubMed ID: 36566501
[TBL] [Abstract][Full Text] [Related]
15. Making innate sense of mRNA vaccine adjuvanticity.
Kobiyama K; Ishii KJ
Nat Immunol; 2022 Apr; 23(4):474-476. PubMed ID: 35354958
[No Abstract] [Full Text] [Related]
16. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
[TBL] [Abstract][Full Text] [Related]
17. The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development.
Kozak M; Hu J
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992279
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review of mRNA Vaccines.
Gote V; Bolla PK; Kommineni N; Butreddy A; Nukala PK; Palakurthi SS; Khan W
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769023
[TBL] [Abstract][Full Text] [Related]
19. Advancing mRNA technologies for therapies and vaccines: An African context.
Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K
Front Immunol; 2022; 13():1018961. PubMed ID: 36353641
[TBL] [Abstract][Full Text] [Related]
20. Innate sensors that regulate vaccine responses.
Georg P; Sander LE
Curr Opin Immunol; 2019 Aug; 59():31-41. PubMed ID: 30978666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
